Financial Gravity Companies Inc. purchased a new position in shares of CME Group Inc (NASDAQ:CME) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 351 shares of the financial services provider’s stock, valued at approximately $64,000.

A number of other institutional investors also recently made changes to their positions in CME. BlackRock Inc. boosted its position in CME Group by 1.8% in the third quarter. BlackRock Inc. now owns 22,422,112 shares of the financial services provider’s stock worth $3,816,468,000 after purchasing an additional 403,327 shares during the last quarter. Capital International Investors boosted its position in CME Group by 18.3% in the third quarter. Capital International Investors now owns 15,425,378 shares of the financial services provider’s stock worth $2,625,554,000 after purchasing an additional 2,383,280 shares during the last quarter. Capital Research Global Investors boosted its position in CME Group by 107.8% in the third quarter. Capital Research Global Investors now owns 10,906,683 shares of the financial services provider’s stock worth $1,856,427,000 after purchasing an additional 5,658,108 shares during the last quarter. Edgewood Management LLC boosted its position in CME Group by 9.5% in the third quarter. Edgewood Management LLC now owns 8,582,518 shares of the financial services provider’s stock worth $1,460,830,000 after purchasing an additional 742,067 shares during the last quarter. Finally, Janus Henderson Group PLC boosted its position in CME Group by 3.3% in the third quarter. Janus Henderson Group PLC now owns 6,331,522 shares of the financial services provider’s stock worth $1,077,689,000 after purchasing an additional 202,365 shares during the last quarter. Institutional investors and hedge funds own 90.59% of the company’s stock.

Several research analysts have weighed in on CME shares. Bank of America reissued a “neutral” rating and issued a $191.00 price objective (down previously from $200.00) on shares of CME Group in a research report on Friday, January 11th. They noted that the move was a valuation call. UBS Group cut CME Group from a “buy” rating to a “neutral” rating and boosted their price objective for the stock from $185.00 to $204.00 in a research report on Wednesday, November 28th. Jefferies Financial Group reaffirmed a “buy” rating and set a $204.00 price target on shares of CME Group in a research report on Wednesday, January 9th. Citigroup started coverage on CME Group in a research report on Tuesday, November 20th. They set a “buy” rating and a $220.00 price target on the stock. Finally, Atlantic Securities started coverage on CME Group in a research report on Wednesday, November 28th. They set a “neutral” rating and a $200.00 price target on the stock. Nine investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $195.21.

Shares of NASDAQ CME opened at $177.32 on Tuesday. CME Group Inc has a one year low of $153.90 and a one year high of $197.08. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.09 and a current ratio of 1.09. The firm has a market cap of $60.56 billion, a PE ratio of 37.17, a PEG ratio of 2.18 and a beta of 0.30.

The company also recently declared a quarterly dividend, which will be paid on Monday, March 25th. Stockholders of record on Friday, March 8th will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.69%. The ex-dividend date is Thursday, March 7th. This is a boost from CME Group’s previous quarterly dividend of $0.70. CME Group’s dividend payout ratio is currently 58.70%.

In related news, CFO John W. Pietrowicz sold 17,960 shares of the stock in a transaction dated Wednesday, January 2nd. The stock was sold at an average price of $186.92, for a total transaction of $3,357,083.20. Following the sale, the chief financial officer now owns 44,780 shares of the company’s stock, valued at approximately $8,370,277.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Julie Winkler sold 5,847 shares of the stock in a transaction dated Friday, November 16th. The stock was sold at an average price of $195.01, for a total value of $1,140,223.47. Following the sale, the insider now directly owns 24,255 shares in the company, valued at approximately $4,729,967.55. The disclosure for this sale can be found here. Insiders have sold a total of 52,494 shares of company stock worth $9,967,852 in the last ninety days. Insiders own 0.43% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Financial Gravity Companies Inc. Purchases Shares of 351 CME Group Inc (CME)” was first published by Watch List News and is owned by of Watch List News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.watchlistnews.com/financial-gravity-companies-inc-purchases-shares-of-351-cme-group-inc-cme/2814484.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Read More: What is a blue-chip stock?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.